KalVista Pharmaceuticals, Inc. ($KALV)
Filing Information
| Accession Number | 0001691102-26-000009 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 11, 2026 |
| Document | View SEC Filing |
Transactions
11
Total Shares
640,088
Total Value
$0.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF DEVELOPMENT OFFICER | Common Stock | โ | Jun 11, 2026 | Sale to Issuer | 229,918 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
CHIEF DEVELOPMENT OFFICER | Stock Option (Right to Buy) | Derivative | Jun 11, 2026 | Sale to Issuer | 53,500 | โ | โ | 0 | Direct | โ | View Details | |
CHIEF DEVELOPMENT OFFICER | Stock Option (Right to Buy) | Derivative | Jun 11, 2026 | Sale to Issuer | 52,600 | โ | โ | 0 | Direct | โ | View Details | |
CHIEF DEVELOPMENT OFFICER | Stock Option (Right to Buy) | Derivative | Jun 11, 2026 | Sale to Issuer | 27,900 | โ | โ | 0 | Direct | โ | View Details | |
CHIEF DEVELOPMENT OFFICER | Stock Option (Right to Buy) | Derivative | Jun 11, 2026 | Sale to Issuer | 60,000 | โ | โ | 0 | Direct | โ | View Details | |
CHIEF DEVELOPMENT OFFICER | Stock Option (Right to Buy) | Derivative | Jun 11, 2026 | Sale to Issuer | 31,000 | โ | โ | 0 | Direct | โ | View Details | |
CHIEF DEVELOPMENT OFFICER | Stock Option (Right to Buy) | Derivative | Jun 11, 2026 | Sale to Issuer | 20,000 | โ | โ | 0 | Direct | โ | View Details | |
CHIEF DEVELOPMENT OFFICER | Stock Option (Right to Buy) | Derivative | Jun 11, 2026 | Sale to Issuer | 18,920 | โ | โ | 0 | Direct | โ | View Details | |
CHIEF DEVELOPMENT OFFICER | Stock Option (Right to Buy) | Derivative | Jun 11, 2026 | Sale to Issuer | 80,000 | โ | โ | 0 | Direct | โ | View Details | |
CHIEF DEVELOPMENT OFFICER | Restricted Stock Unit | Derivative | Jun 11, 2026 | Sale to Issuer | 25,000 | โ | โ | 0 | Direct | โ | View Details | |
CHIEF DEVELOPMENT OFFICER | Restricted Stock Unit | Derivative | Jun 11, 2026 | Sale to Issuer | 41,250 | โ | โ | 0 | Direct | โ | View Details |